Does TOFACITINIB Cause Skin lesion? 478 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 478 reports of Skin lesion have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.3% of all adverse event reports for TOFACITINIB.
478
Reports of Skin lesion with TOFACITINIB
0.3%
of all TOFACITINIB reports
8
Deaths
71
Hospitalizations
How Dangerous Is Skin lesion From TOFACITINIB?
Of the 478 reports, 8 (1.7%) resulted in death, 71 (14.9%) required hospitalization, and 2 (0.4%) were considered life-threatening.
Is Skin lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 478 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Skin lesion?
SECUKINUMAB (1,909)
ADALIMUMAB (1,507)
METHOTREXATE (1,237)
DUPILUMAB (685)
ETANERCEPT (647)
PREDNISONE (617)
INFLIXIMAB (474)
CYCLOSPORINE (380)
LENALIDOMIDE (369)
TACROLIMUS (366)
Which TOFACITINIB Alternatives Have Lower Skin lesion Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN